Friday 6 November 2026 Export DGX’s income statement to Excel — free account

Quest Diagnostics Incorporated

DGX Healthcare Diagnostics & Research

Quest Diagnostics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $11.0 billion, up 11.8% from fiscal 2024.

Revenue: +9.98%
EPS: +29.4%
Free cash flow: +6.21%
Total debt: −2.20%

Quarter to September 2026, against a year earlier

255.89 1.15 +0.45%

Follow DGX

Alert me

Market cap: $28.0B
P/E: 25.0×
Fwd P/E: 24.4×
Dividend yield: 1.33%
F-score: 8/9
Altman Z: 3.15
Beneish M: −2.65
Dividend safety: 85/100

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Quest Diagnostics Incorporated 10-K filed Feb 20, 2025

Fiscal year 2024 · Period ended Dec 31, 2024 · Filed Feb 20, 2025 · accepted 4:30 PM ET · Document on sec.gov · Filing index

What changed

Item 1, Business Item 1A, Risk Factors Item 7, Management’s Discussion and Analysis

Item 1, Business: no comparison — no earlier filing on file